82 related articles for article (PubMed ID: 10232740)
1. Defective anticarbohydrate antibody responses to naturally occurring bacteria following bone marrow transplantation.
Kapoor N; Chan R; Weinberg KI; Burotto F; Parkman R
Biol Blood Marrow Transplant; 1999; 5(1):46-50. PubMed ID: 10232740
[TBL] [Abstract][Full Text] [Related]
2. Polysaccharide antibody responses are impaired post bone marrow transplantation for severe combined immunodeficiency, but not other primary immunodeficiencies.
Slatter MA; Bhattacharya A; Flood TJ; Spickett GP; Cant AJ; Abinun M; Gennery AR
Bone Marrow Transplant; 2003 Jul; 32(2):225-9. PubMed ID: 12838289
[TBL] [Abstract][Full Text] [Related]
3. Immune response to polio vaccination in bone marrow transplant recipients.
Engelhard D; Handsher R; Naparstek E; Hardan I; Strauss N; Aker M; Or R; Baciu H; Slavin S
Bone Marrow Transplant; 1991 Oct; 8(4):295-300. PubMed ID: 1661633
[TBL] [Abstract][Full Text] [Related]
4. Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients.
Parkkali T; Käyhty H; Lehtonen H; Ruutu T; Volin L; Eskola J; Ruutu P
Bone Marrow Transplant; 2001 Jan; 27(1):79-84. PubMed ID: 11244441
[TBL] [Abstract][Full Text] [Related]
5. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
[TBL] [Abstract][Full Text] [Related]
6. Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow.
Norhagen G; Engström PE; Björkstrand B; Hammarström L; Smith CI; Ringdén O
Bone Marrow Transplant; 1994 Aug; 14(2):229-34. PubMed ID: 7994237
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.
Gandhi MK; Egner W; Sizer L; Inman I; Zambon M; Craig JI; Marcus RE
Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630
[TBL] [Abstract][Full Text] [Related]
8. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.
Yoshikawa T; Asano Y; Ihira M; Suzuki K; Ohashi M; Suga S; Kudo K; Horibe K; Kojima S; Kato K; Matsuyama T; Nishiyama Y
J Infect Dis; 2002 Apr; 185(7):847-53. PubMed ID: 11920307
[TBL] [Abstract][Full Text] [Related]
9. [Kinetics of vaccination antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogenic and autologous bone marrow transplantation and booster vaccination. 2: Kinetics of vaccination antibodies against diphtheria toxoid after allogenic and autologous bone marrow transplantation].
Prager J; Thilo W; Hermann J; Fuchs D; Zintl F
Kinderarztl Prax; 1992 Oct; 60(7):195-8. PubMed ID: 1434337
[TBL] [Abstract][Full Text] [Related]
10. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
[TBL] [Abstract][Full Text] [Related]
11. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
13. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.
Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK
Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
15. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
[TBL] [Abstract][Full Text] [Related]
17. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
[TBL] [Abstract][Full Text] [Related]
18. Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin.
Bacigalupo A; Oneto R; Bruno B; Soracco M; Lamparelli T; Gualandi F; Occhini D; Raiola A; Mordini N; Berisso G; Bregante S; Dini G; Lombardi A; Lint MV; Brand R
Bone Marrow Transplant; 1999 Sep; 24(6):653-9. PubMed ID: 10490732
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
[TBL] [Abstract][Full Text] [Related]
20. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
